NASDAQ:HRTX

Heron Therapeutics Stock Predictions

etoro logo Buy HRTX
*Your capital is at risk
$0.447
-0.0032 (-0.711%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

HRTX Prediction Chart

HRTX Predictions History

Latest community submissions for HRTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 28, 2024 $2.79 +1.77% $2.70 X 96.73% 0
Feb 28, 2024 Bullish $2.70 V 0
Feb 20, 2024 $2.79 -2.83% $2.87 X 97.17% 0
Feb 20, 2024 $2.82 -1.77% $2.87 X 98.23% 0
Skagitqg Skagitqg Merchant
Feb 20, 2024 Bullish $2.87 X 0
Jan 29, 2024 $2.41 -3.41% $2.53 X 95.06% 0
Jan 29, 2024 $2.44 -2.13% $2.53 X 96.32% 0
Jan 29, 2024 Bullish $2.53 V 1
Jan 24, 2024 $2.50 +13.64% $2.62 V 95.60% 1
Aug 14, 2023 $1.68 +3.47% $1.51 X 88.99% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for HRTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT HERON THERAPEUTICS
Heron Therapeutics
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acut...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE